The central cannabinoid receptor type-2 (CB2) and chronic pain

被引：30
作者：
Shang, Yuchao [1 ,2 ]
Tang, Yuying [1 ,2 ]
机构：
[1] Sichuan Univ, West China Hosp 2, Dept Anesthesiol, Chengdu, Peoples R China
[2] Sichuan Univ, Minist Educ, Key Lab Birth Defects & Related Dis Women & Child, Chengdu, Peoples R China
来源：
INTERNATIONAL JOURNAL OF NEUROSCIENCE | 2017年 / 127卷 / 09期
基金：
中国国家自然科学基金;
关键词：
Cannabinoid; CB2; pain; analgesia; clinical; RANDOMIZED CONTROLLED-TRIAL; CHRONIC NEUROPATHIC PAIN; INCREASES INTRACELLULAR CALCIUM; ACTIVATED PROTEIN-KINASE; SPINAL DORSAL-HORN; MULTIPLE-SCLEROSIS; GLIAL ACTIVATION; NERVE INJURY; PHARMACOLOGICAL CHARACTERIZATION; IN-VITRO;
D O I：
10.1080/00207454.2016.1257992
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
Cannabinoid receptor type-2 (CB2, CB2 receptor or CB2-R) mediates analgesia via two mechanisms. CB2 receptors contained in peripheral immune tissue mediate analgesia by altering cytokine profiles, and thus have little adverse effects on central nervous systems (CNSs). CB2 is also expressed in the neurons and glial cells of the CNS. This neuronal expression may also contribute to pain attenuation. The CB2 receptor has been proposed as a potential target in treating chronic pain of several etiologies.
引用
收藏
页码：812 / 823
页数：12
相关论文
共 118 条
[1]  
[Anonymous], 2010, CAN MED ASSOC J, DOI DOI 10.1503/cmaj.091414
[2]   Expression of the cannabinoid CB2 receptor in the rat cerebellum: An immunohistochemical study [J].
Ashton, JC ;
Friberg, D ;
Darlington, CL ;
Smith, PF .
NEUROSCIENCE LETTERS, 2006, 396 (02) :113-116
[3]   Functional Selectivity in CB2 Cannabinoid Receptor Signaling and Regulation: Implications for the Therapeutic Potential of CB2 Ligands [J].
Atwood, Brady K. ;
Wager-Miller, James ;
Haskins, Christopher ;
Straiker, Alex ;
Mackie, Ken .
MOLECULAR PHARMACOLOGY, 2012, 81 (02) :250-263
[4]   CB2: a cannabinoid receptor with an identity crisis [J].
Atwood, Brady K. ;
Mackie, Ken .
BRITISH JOURNAL OF PHARMACOLOGY, 2010, 160 (03) :467-479
[5]   CB2 receptor-mediated antihyperalgesia: possible direct involvement of neural mechanisms [J].
Beltramo, M ;
Bernardini, N ;
Bertorelli, R ;
Campanella, M ;
Nicolussi, E ;
Fredduzzi, S ;
Reggiani, A .
EUROPEAN JOURNAL OF NEUROSCIENCE, 2006, 23 (06) :1530-1538
[6]  
Beltramo Massimiliano, 2009, Journal de la Societe de Biologie, V203, P99, DOI 10.1051/jbio:2009002
[7]   A glial endogenous cannabinoid system is upregulated in the brains of macaques with simian immunodeficiency virus-induced encephalitis [J].
Benito, C ;
Kim, WK ;
Chavarría, I ;
Hillard, CJ ;
Mackie, K ;
Tolón, RM ;
Williams, K ;
Romero, J .
JOURNAL OF NEUROSCIENCE, 2005, 25 (10) :2530-2536
[8]   Experience with the synthetic cannabinoid nabilone in chronic noncancer pain [J].
Berlach, DM ;
Shir, Y ;
Ware, MA .
PAIN MEDICINE, 2006, 7 (01) :25-29
[9]  
Bethea JR, 1998, J NEUROSCI, V18, P3251
[10]   N-acyl-dopamines:: novel synthetic CB1 cannabinoid-receptor ligands and inhibitors of anandamide inactivation with cannabimimetic activity in vitro and in vivo [J].
Bisogno, T ;
Melck, D ;
Bobrov, MY ;
Gretskaya, NM ;
Bezuglov, VV ;
De Petrocellis, L ;
Di Marzo, V .
BIOCHEMICAL JOURNAL, 2000, 351 (03) :817-824
12345678910